Today: 2 July 2026
Browse Category

NASDAQ:MGRX 13 November 2025 - 23 February 2026

Mangoceuticals (MGRX) Soars on Eli Lilly and Novo Nordisk Deal as It Launches MangoRx Direct for Obesity Drugs

Mangoceuticals (MGRX) Soars on Eli Lilly and Novo Nordisk Deal as It Launches MangoRx Direct for Obesity Drugs

Mangoceuticals, Inc., the tiny telehealth company best known for its MangoRx men’s wellness brand, is suddenly at the center of the red‑hot obesity drugs market after unveiling a partnership with Eli Lilly and Novo Nordisk to offer official access to their blockbuster GLP‑1 weight‑loss medications Zepbound and Wegovy.GlobeNewswire+1 In a press release and accompanying SEC Form 8‑K filed Thursday, Mangoceuticals said it has launched two integrated programs — MangoRx Direct and PeachesRx Direct — built around official access to GLP‑1 obesity drugs from Eli Lilly and Novo Nordisk.GlobeNewswire+2SEC+2
13 November 2025
····

Stock Market Today

  • Haleon CFO Dawn Allen Gets Share Award, Sells Part to Pay Tax
    July 2, 2026, 10:30 AM EDT. Haleon PLC (LSE/NYSE: HLN) said CFO Dawn Allen was given a Performance Share Plan award that vests June 30, 2026. She got 283,193 shares under the 2024 plan, based on targets through December 2025. Allen sold 133,301 shares at £3.52 each in London to cover taxes owed from the vesting. Shares include dividends and are subject to malus and clawback. The company made the disclosure under UK rules and reminded that execs have to hold shares for two years after they vest. Details will be in next year's annual report and 20-F.
Go toTop